The use of robotics has gained popularity in recent years partly due to its minimally invasive surgery capabilities and potential for improved outcomes. From 2005 to 2012, the use of robotics in the United States jumped from 25,000 cases per year to 450,000 cases per year, according to the U.S. Food and Drug Administration.
Dallas-based MD Buyline, a supply chain management solutions provider, outlines four financial and clinical considerations to address when looking at soft tissue robots.
1. Cost of ownership. The upfront cost of current soft tissue robotic technology can be more than $1.5 million. Then, providers need to consider case-by-case consumable costs and yearly services costs, which can add up to $6,000 per patient. Hospitals also need to factor in training costs, which start at approximately $20,000 per surgeon.
2. Increased surgical costs. According to the report, robotic-assisted soft tissue surgery tends to have longer operative times and higher operational costs compared to open or laparoscopic procedures. One study found the average total cost increase for robotic-assisted laparoscopic surgery was between $3,850 and $15,320 compared to open procedures.
3. Reduced length of stay. However, such surgeries are also associated with shorter LOS and less blood loss. One analysis found LOS following robotic-assisted laparoscopic surgery was 2.4 days less than open surgery, and mortality rates were significantly less as well.
4. Break-even costs. MD Buyline expects future generations of soft tissue robots to decrease in price as the technology matures and other competitors enter the market.
More Articles on Robots:
18 Hospitals, Health Systems That Recently Added UV Disinfection Robots
Specialists at University of Utah Use Telemedicine Robot to Provide Care at Community Hospital
4 Things to Know About Robotic-Assisted Lung Surgery, Outcomes